Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02566980 · ClinicalTrials.gov registry record
Biological Triggers of Depression in Pregnancy
A clinical trial, sponsored by Michigan State University.
- Completed
- Registry status
- 209
- Enrollment target
NCT02566980: Completed study, sponsored by Michigan State University.
NCT02566980 is a clinical trial that has completed, run by Michigan State University. The registered enrollment target is 209 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02566980 has completed, sponsored by Michigan State University.
- COMPLETED
- Registry status
- 209 participants
- Enrollment target
Study Summary
The goal of the study is to define and measure biological processes that contribute to the underlying pathophysiologic process of peri-partum depression to be used for identifying those at risk for developing it. This knowledge may also generate novel drug targets for peripartum depression that may be applicable to other types of depression.
Primary Outcome
Blood levels of quinolinic acid and picolinic acid (product of ACMSD) at three timepoints during pregnancy and one time-point after pregnancy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 209 participants |
| Start Date | 2014-10-23 |
| Est. Completion | 2017-02-28 |
What the finished NCT02566980 record still lists
NCT02566980 is an observational study that tracks outcomes without assigning an intervention. The registered 209 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT02566980 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02566980 about?
NCT02566980 is a clinical study titled "Biological Triggers of Depression in Pregnancy". The goal of the study is to define and measure biological processes that contribute to the underlying pathophysiologic process of peri-partum depression to be used for identifying those at risk for developing it. This knowledge may also generate novel drug targets for peripartum depression that may ...
What is the current status of trial NCT02566980?
This trial is currently completed. The enrollment target is 209 participants. The study started on 2014-10-23. Estimated completion is 2017-02-28.
Who is sponsoring clinical trial NCT02566980?
This trial is sponsored by Michigan State University, which has 120 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04742634 · 209 participants · Phase 1
Pre-emptive Therapy With DEC-C to Improve Outcomes in MDS Patients With Measurable Residual Disease Post Allogeneic Hematopoietic Cell Transplant
- NCT07214688 · 209 participants · Phase 2
Fludarabine and Intermediate-dose TBI Followed by PTCy in Patients Undergoing Allo Transplant for Heme Malignancies
- NCT02665923 · 210 participants
Gastric Emptying in Neonates and Infants After Formula Feeding
- NCT03322891 · 210 participants · NA
Improving Health Literacy in African-American Prostate Cancer Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI